Press Releases

New indication in pediatric patients, including term neonates for Guerbet’s hal…
Karim Boussebaa Appointed Chief Executive Officer of Guerbet
Celebrating 100 Years Visibly Different
RSNA 2025
Top Medical Imaging Company and Provider of Diagnostic Imaging Collaborate to E…
Guerbet Reports Recording-Breaking Demand for Dotarem
Guerbet Announces Key Research and Educational Grants and Partnerships
Guerbet provides 100 academic scholarships for students
US FDA Approves Guerbet's Optiray® (Ioversol Injection) Imaging Bulk Package
Guerbet Announces FDA Approval For U.S. Dotarem (gadoterate meglumine) Injectio…

Media Relations

Guerbet North America

US (877) 729-6679